BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23517562)

  • 21. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study.
    Yhim HY; Park Y; Kim JA; Shin HJ; Do YR; Moon JH; Kim MK; Lee WS; Kim DS; Lee MW; Choi YS; Jeong SH; Kim KH; Kim J; Lee CH; Song GY; Yang DH; Kwak JY
    Korean J Intern Med; 2024 May; 39(3):501-512. PubMed ID: 38287501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
    Cencini E; Tucci A; Puccini B; Cavallo F; Luminari S; Usai SV; Fabbri A; Pennese E; Marino D; Zilioli VR; Balzarotti M; Petrucci L; Tafuri A; Arcari A; Botto B; Zanni M; Hohaus S; Sartori R; Merli M; Gini G; Al Essa W; Musurca G; Tani M; Nassi L; Daffini R; Mammi C; Marcheselli L; Bocchia M; Spina M; Merli F
    Hematol Oncol; 2023 Feb; 41(1):78-87. PubMed ID: 36177902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.
    Chiappella A; Castellino A; Nicolosi M; Santambrogio E; Vitolo U
    Expert Rev Hematol; 2017 Apr; 10(4):289-297. PubMed ID: 28290728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients.
    Naito Y; Sasaki H; Takamatsu Y; Kiyomi F; Tamura K
    J Clin Exp Hematop; 2016; 56(1):43-9. PubMed ID: 27334857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
    Chihara D; Westin JR; Oki Y; Ahmed MA; Do B; Fayad LE; Hagemeister FB; Romaguera JE; Fanale MA; Lee HJ; Turturro F; Samaniego F; Neelapu SS; Rodriguez MA; Fowler NH; Wang M; Davis RE; Nastoupil LJ
    Cancer; 2016 Oct; 122(20):3145-3151. PubMed ID: 27351173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions.
    Gobba S; Moccia AA; Gulden-Sala W; Conconi A; Diem S; Cascione L; Iacoboni G; Margiotta-Casaluci G; Aprile von Hohenstaufen K; Stathis A; Hitz F; Pinotti G; Gaidano G; Zucca E
    Hematol Oncol; 2018 Feb; 36(1):84-92. PubMed ID: 28621491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
    Marchesi F; Cenfra N; Altomare L; Dessanti ML; Mecarocci S; Cerchiara E; Rago A; D'Andrea M; Tomarchio V; Olimpieri OM; Tirindelli MC; Mengarelli A; Petti MC; Avvisati G; Cimino G
    J Geriatr Oncol; 2013 Jul; 4(3):242-8. PubMed ID: 24070462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi.
    Visco C; Chiappella A; Nassi L; Patti C; Ferrero S; Barbero D; Evangelista A; Spina M; Molinari A; Rigacci L; Tani M; Rocco AD; Pinotti G; Fabbri A; Zambello R; Finotto S; Gotti M; Carella AM; Salvi F; Pileri SA; Ladetto M; Ciccone G; Gaidano G; Ruggeri M; Martelli M; Vitolo U
    Lancet Haematol; 2017 Jan; 4(1):e15-e23. PubMed ID: 27927586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.
    Liu H; Zhang CL; Feng R; Li JT; Tian Y; Wang T
    Oncologist; 2018 Jun; 23(6):722-729. PubMed ID: 29317552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy.
    Ciammella P; Filippi AR; Simontacchi G; Buglione M; Furlan C; Spina M; Tucci A; Rigacci L; Iotti C; Vitolo U; Ricardi U; Merli F
    Leuk Lymphoma; 2016 Nov; 57(11):2677-80. PubMed ID: 26926887
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
    Melén CM; Enblad G; Sonnevi K; Junlén HR; Smedby KE; Jerkeman M; Wahlin BE
    Br J Haematol; 2016 Nov; 175(4):614-622. PubMed ID: 27790699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
    Tarella C; Zanni M; Di Nicola M; Patti C; Calvi R; Pescarollo A; Zoli V; Fornari A; Novero D; Cabras A; Stella M; Comino A; Remotti D; Ponzoni M; Caracciolo D; Ladetto M; Magni M; Devizzi L; Rosato R; Boccadoro M; Bregni M; Corradini P; Gallamini A; Majolino I; Mirto S; Gianni AM;
    Leukemia; 2007 Aug; 21(8):1802-11. PubMed ID: 17554382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment Individualization in Diffuse Large B-Cell Lymphoma: Is Frailty Enough for Old Adults? An Original Article.
    García-Baztán A; Oteiza-Olaso J; Gonzales-Montejo NJ; Ramón-Espinoza MF; Tamayo-Rodríguez I; Martínez-Velilla N; Viguria-Alegria MC
    Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):e348-e359. PubMed ID: 37487908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
    Miura K; Konishi J; Miyake T; Makita M; Hojo A; Masaki Y; Uno M; Ozaki J; Yoshida C; Niiya D; Kitazume K; Maeda Y; Takizawa J; Sakai R; Yano T; Yamamoto K; Sunami K; Hiramatsu Y; Aoyama K; Tsujimura H; Murakami J; Hatta Y; Kanno M
    Oncologist; 2017 May; 22(5):554-560. PubMed ID: 28408622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program.
    Basso U; Tonti S; Bassi C; Brunello A; Pasetto LM; Scaglione D; Falci C; Beda M; Aversa SM; Stefani M; Castegnaro E; Tamellini F; Monfardini S
    Crit Rev Oncol Hematol; 2008 May; 66(2):163-70. PubMed ID: 18243726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
    Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
    Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.